Viewing Study NCT03309592


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-27 @ 5:11 AM
Study NCT ID: NCT03309592
Status: WITHDRAWN
Last Update Posted: 2018-12-07
First Post: 2017-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
Sponsor: Ochsner Health System
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2018-11-01
Primary Completion Date Type: ACTUAL
Completion Date: 2018-11-01
Completion Date Type: ACTUAL
First Submit Date: 2017-06-05
First Submit QC Date: None
Study First Post Date: 2017-10-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-12-05
Last Update Post Date: 2018-12-07
Last Update Post Date Type: ACTUAL